GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICARES Medicus Inc (ROCO:6612) » Definitions » Investments And Advances

ICARES Medicus (ROCO:6612) Investments And Advances : NT$0.0 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is ICARES Medicus Investments And Advances?

ICARES Medicus's Investments And Advances for the quarter that ended in Mar. 2025 was NT$0.0 Mil.


ICARES Medicus Investments And Advances Historical Data

The historical data trend for ICARES Medicus's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ICARES Medicus Investments And Advances Chart

ICARES Medicus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ICARES Medicus Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ICARES Medicus Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


ICARES Medicus Business Description

Traded in Other Exchanges
N/A
Address
Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are the U.S.A., which derives maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, Taiwan, China, and other countries.

ICARES Medicus Headlines

No Headlines